Retatrutide helped trial participants lose up to 28.7% of their body weight, but experts warn about excessive weight loss.

Obesity among adults and children in the US is still on the rise, despite the boom of weight-loss medications like Ozempic, a ...

If you're looking for ways to mitigate your risk of developing cardiovascular disease or experiencing a cardiac event, such as a heart attack or stroke, glucagon-like peptide-1 (GLP-1) ...

The global obesity crisis tells a story of two worlds. In some corners of the planet, obesity is virtually unknown, where ...

Scientists from SLUHN Family Medicine Residency–Warren and other institutions have found that plant-based diets may play a major role in preventing obesity and related chronic diseases. Obesity is ...

Dr. Mark Hyman calls new nutrition guidelines "revolutionary" for targeting processed foods and sugar drinks, despite dairy ...

U.S. policymakers use a secret weapon to uncover widespread threats to public health. This tool enabled them to discover that ...

A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.

Metabolic-treatment-experts-highlight-evolving-obesity-care-and-individualized-plans-combining-medication-and-surgery-for-lasting-results ...

A new Lancet study challenges how we define obesity — and, in doing so, exposes the failure of decades of efforts to combat it. The study recommends looking beyond body mass index (BMI) to metrics of ...

America’s obesity problem is tipping the scales. A staggering 47% of American adults will be living with obesity by 2035, a new study published in JAMA projects, citing the country’s rapidly rising ...